Cargando…
Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis
Psoriasis is a prevalent chronic inflammatory human disease initiated by impaired function of immune cells and epidermal keratinocytes, resulting in increased cytokine production and hyperproliferation, leading to skin lesions. Overproduction of Th1- and Th17-cytokines including interferon (IFN)-γ,...
Autores principales: | Sevilla, Lisa M., Pérez, Paloma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753639/ https://www.ncbi.nlm.nih.gov/pubmed/31572404 http://dx.doi.org/10.3389/fimmu.2019.02220 |
Ejemplares similares
-
Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ)
por: Dankers, Wendy, et al.
Publicado: (2022) -
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021) -
Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss
por: Yang, Nianlan, et al.
Publicado: (2017) -
Glucocorticoid-induced leucine zipper (GILZ) in immuno suppression: master regulator or bystander?
por: Hoppstädter, Jessica, et al.
Publicado: (2015) -
Amplified Host Defense by Toll-Like Receptor-Mediated Downregulation of the Glucocorticoid-Induced Leucine Zipper (GILZ) in Macrophages
por: Hoppstädter, Jessica, et al.
Publicado: (2019)